Drug Shortage Report for SPRYCEL
Report ID | 16413 |
Drug Identification Number | 02360810 |
Brand name | SPRYCEL |
Common or Proper name | dasatinib |
Company Name | BRISTOL-MYERS SQUIBB CANADA |
Market Status | MARKETED |
Active Ingredient(s) | DASATINIB |
Strength(s) | 80MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 1 BTL X 30 |
ATC code | L01XE |
ATC description | OTHER ANTINEOPLASTIC AGENTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2017-08-04 |
Actual start date | |
Estimated end date | 2017-08-04 |
Actual end date | 2017-08-03 |
Shortage status | Avoided shortage |
Updated date | 2017-08-02 |
Company comments | Product on allocation, other strengths are available. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2344 BOUL. ALFRED-NOBEL, SUITE 300 ST-LAURENT, QUEBEC CANADA H4S 0A4 |
Company contact information | For more information please contact the Customer Service Desk at 1-800-267-0005 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2017-08-02 | French | Compare |
v5 | 2017-08-02 | English | Compare |
v4 | 2017-07-29 | French | Compare |
v3 | 2017-07-29 | English | Compare |
v2 | 2017-07-19 | French | Compare |
v1 | 2017-07-19 | English | Compare |
Showing 1 to 6 of 6